Can a second surgery extend life for women with recurring ovarian cancer?
NCT ID NCT07171528
Summary
This study is testing whether adding surgery after chemotherapy helps control recurrent ovarian cancer better than chemotherapy alone. It will enroll 80 women whose ovarian cancer has returned but is still responding to platinum-based drugs. Researchers will compare how long patients live without their cancer getting worse between the group that gets surgery plus chemo and the group that gets only chemo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Cancer Center, Korea
RECRUITINGGoyang-si, Gyeonggi-do, 10408, South Korea
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.